Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Invivo Therapeutics Holdings Corp. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q4 2022
- Shares held
- 116.4K
- −189.5K (−61.9%) vs. Q4 2022
- Total value
- $123.7K
- −$595.0K (−82.8%) vs. Q4 2022
- New holders
- 7
- 2 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $5.22K |
| Q4 2023 | 14 | $68.1K |
| Q3 2023 | 15 | $118.5K |
| Q2 2023 | 15 | $131.0K |
| Q1 2023 | 20 | $123.7K |
| Q4 2022 | 17 | $718.7K |
| Q3 2022 | 16 | $703.0K |
| Q2 2022 | 13 | $257.0K |
| Q1 2022 | 1 | $1.00K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Invivo Therapeutics Holdings Corp.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 69 | $0 | 0.00% | 00.0% | Unchanged |
| Sugarloaf Wealth Management, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% | +1 | New |
| Colonial Trust Advisors | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $2 | 0.00% | +1 | New |
| Milestone Investment Advisors LLC | 1 | $2 | 0.00% | +1 | New |
| Advisor Group Holdings, Inc. | 7 | $7 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 6 | $8 | 0.00% | +6 | New |
| Wells Fargo & Company | 13 | $14 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 20 | $21 | 0.00% | +20 | New |
| Morgan Stanley | 1,469 | $1.56K | 0.00% | −31−2.1% | Reduced |
| Tower Research Capital LLC (TRC) | 1,784 | $2.00K | 0.00% | −3,363−65.3% | Reduced |
| UBS Group AG | 3,740 | $3.96K | 0.00% | −527−12.4% | Reduced |
| Geode Capital Management, LLC | 11,169 | $11.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,025 | $12.0K | 0.00% | +900+8.9% | Added |
| Two Sigma Securities, LLC | 12,870 | $13.6K | 0.00% | +12,870 | New |
| Millennium Management LLC | 13,280 | $14.0K | 0.00% | +13,280 | New |
| Vanguard Group Inc | 26,246 | $27.8K | 0.00% | +9,300+54.9% | Added |
| BlackRock Inc. | 34,714 | $36.8K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −222,000−100.0% | Sold out |
| Coastal Capital Group, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |